{"id":5325,"date":"2016-10-23T08:00:23","date_gmt":"2016-10-23T06:00:23","guid":{"rendered":"https:\/\/asscat-hepatitis.org\/encuesta-de-calidad-de-vida-en-personas-que-tienen-o-han-tenido-hepatitis-c\/"},"modified":"2018-07-04T17:42:56","modified_gmt":"2018-07-04T15:42:56","slug":"enquesta-de-qualitat-de-vida-en-persones-que-tenen-o-han-tingut-hepatitis-c","status":"publish","type":"post","link":"https:\/\/asscat-hepatitis.org\/ca\/enquesta-de-qualitat-de-vida-en-persones-que-tenen-o-han-tingut-hepatitis-c\/","title":{"rendered":"Enquesta de Qualitat de Vida en persones que tenen o han tingut Hepatitis C"},"content":{"rendered":"<p>[et_pb_section bb_built=&#8221;1&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;3.0.106&#8243; custom_margin=&#8221;|||&#8221; custom_padding=&#8221;0px||0px|&#8221; next_background_color=&#8221;#000000&#8243;][et_pb_row custom_padding=&#8221;0px||0px|&#8221; _builder_version=&#8221;3.0.106&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_post_title author=&#8221;off&#8221; date_format=&#8221;d\/m\/Y&#8221; comments=&#8221;off&#8221; featured_placement=&#8221;background&#8221; text_background=&#8221;on&#8221; text_bg_color=&#8221;#ffffff&#8221; module_class=&#8221;ac-post-title-section-0&#8243; _builder_version=&#8221;3.0.106&#8243; title_font=&#8221;Montserrat|600|||||||&#8221; title_text_color=&#8221;#2d2d2d&#8221; title_letter_spacing=&#8221;-1px&#8221; title_line_height=&#8221;1.2em&#8221; meta_font=&#8221;Open Sans||||||||&#8221; meta_text_color=&#8221;rgba(45,45,45,0.5)&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;|||&#8221; custom_padding=&#8221;|20px|20px|20px&#8221; title_text_align=&#8221;center&#8221; meta_font_size=&#8221;13px&#8221; meta_text_align=&#8221;center&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.0.106&#8243; custom_padding=&#8221;0px|||&#8221; prev_background_color=&#8221;#000000&#8243; next_background_color=&#8221;#000000&#8243;][et_pb_column type=&#8221;2_3&#8243; specialty_columns=&#8221;2&#8243;][et_pb_row_inner admin_label=&#8221;Fila&#8221; _builder_version=&#8221;3.0.106&#8243;][et_pb_column_inner type=&#8221;4_4&#8243; saved_specialty_column_type=&#8221;2_3&#8243;][et_pb_text admin_label=&#8221;Contenido Entrada 1&#8243; ul_type=&#8221;square&#8221; module_class=&#8221;ac-posts-content&#8221; _builder_version=&#8221;3.0.106&#8243; text_orientation=&#8221;justified&#8221; background_layout=&#8221;light&#8221;]<\/p>\n<h3><span lang=\"ES-TRAD\">L&#8217;ASSCAT i gTt-VIH, en col\u00b7laboraci\u00f3 amb el CEEISCAT, posen en marxa un estudi per con\u00e8ixer quina \u00e9s la percepci\u00f3 que sobre la seva salut tenen les persones que han tingut o tenen hepatitis C.<\/span><\/h3>\n<p>Les conclusions de diversos estudis realitzats al llarg de les \u00faltimes d\u00e8cades indiquen que les persones amb hepatitis C no nom\u00e9s veuen afectada la seva qualitat de vida per factors de tipus fisiol\u00f2gic, sin\u00f3 que tamb\u00e9 presenten diverses manifestacions de problemes i trastorns psicol\u00f2gics. D&#8217;una banda, els pacients amb hepatitis C perceben que pateixen una malaltia greu; tenen dificultat per acceptar-la i adaptar-se a les conseq\u00fc\u00e8ncies a llarg termini i, d&#8217;altra banda, es senten discriminats i estigmatitzats. Tots aquests factors s&#8217;han associat a un deteriorament en la percepci\u00f3 de la seva qualitat de vida, tant general com relacionada amb la salut, marcada per la incertesa enfront al curs de la seva malaltia.<\/p>\n<p>El mesurament de la qualitat de vida relacionada amb la salut permet avaluar de forma m\u00e9s integral i v\u00e0lida l&#8217;impacte d&#8217;una malaltia i el seu tractament en termes comprensibles pel pacient. No obstant, aquest mesurament, realitzat a trav\u00e9s de q\u00fcestionaris estandarditzats, no est\u00e0 inclosa en el seguiment i control cl\u00ednic dels pacients amb hepatitis C. D&#8217;altra banda, sabem molt poc de la percepci\u00f3 de la qualitat de vida d&#8217;aquells que han aconseguit curar la seva hepatitis C amb l&#8217;\u00fas dels nous antivirals d&#8217;acci\u00f3 directa.<\/p>\n<p>Per aquest motiu, l&#8217;Associaci\u00f3 Catalana de Malalts d&#8217;Hepatitis (ASSCAT), el Grup de Treball sobre Tractaments del VIH (gTt-VIH) i el Centre d&#8217;Estudis Epidemiol\u00f2gics sobre les Infeccions de Transmissi\u00f3 Sexual i Sida de Catalunya (CEEISCAT) t&#8217;animem a participar en aquesta enquesta online.<\/p>\n<p><strong>\u00c9s molt important que completis aquesta enquesta. Fer-ho et portar\u00e0 un temps no superior a 15 minuts.\u00a0<\/strong><span style=\"color: #800000;\"><strong>Fins el 6 d&#8217;abril del 2017 s&#8217;ha pogut completar aquesta enquesta de la qual properament publicarem els resultats.<\/strong><\/span><\/p>\n<p><strong>Si tens (o has tingut) hepatitis C i vius a Espanya ens agradaria con\u00e8ixer com vas adquirir la malaltia, quina \u00e9s l&#8217;atenci\u00f3 cl\u00ednica que reps, si has rebut tractament, com perceps la teva qualitat de vida i la teva experi\u00e8ncia amb les associacions de pacients. La teva col\u00b7laboraci\u00f3 \u00e9s fonamental!<\/strong><\/p>\n<p><strong>Aquesta \u00e9s una enquesta an\u00f2nima i dissenyada perqu\u00e8 puguis donar la teva opini\u00f3 amb total llibertat posant aix\u00ed m\u00e9s \u00e8mfasi en la teva experi\u00e8ncia.<\/strong><\/p>\n<p>El q\u00fcestionari ha estat elaborat per l&#8217;ASSCAT i gTt-VIH en col\u00b7laboraci\u00f3 amb els professionals del CEEISCAT, aquells que realitzaran la recopilaci\u00f3 i an\u00e0lisis dels resultats.\u00a0<strong>Totes les dades seran tractades de forma confidencial i, en cap cas, et farem preguntes que permetin identificar-te.<\/strong><\/p>\n<p>Els resultats que obtinguem els donarem a con\u00e8ixer a trav\u00e9s dels llocs web de\u00a0gTt-VIH (<a href=\"http:\/\/www.gtt-vih.org\">www.gtt-vih.org<\/a>) i de l&#8217;ASSCAT (<a href=\"http:\/\/www.asscat-hepatitis.org\">www.asscat-hepatitis.org<\/a>), i els presentarem a institucions sanit\u00e0ries, congressos m\u00e8dics i altres trobades de salut que es celebrin durant el 2017.\u00a0<strong>Volem ajudar-te a qu\u00e8 la teva veu sigui escoltada per part d&#8217;aquells que prenen decisions importants que t&#8217;afecten.<\/strong><\/p>\n<p>Si tens qualsevol pregunta o dubte, pots contactar amb nosaltres:<\/p>\n<ul>\n<li><strong><a href=\"mailto:investigacion@gtt-vih.org\">investigacion@gtt-vih.org<\/a> o al tel\u00e8fon (+34) 93 208 08 45.<\/strong><\/li>\n<li><strong> <a href=\"mailto:informacio@asscat-hepatitis.org\">informacio@asscat-hepatitis.org<\/a> o al tel\u00e8fon (+34) 93 314 52 09.<\/strong><\/li>\n<\/ul>\n<p><strong><br \/>\n\u00c9s molt important que completis aquesta enquesta. Fer-ho et portar\u00e0 un temps no superior a 15 minuts. Pots accedir a l&#8217;enquesta a trav\u00e9s del seg\u00fcent enlla\u00e7:<\/strong><strong>\u00a0<\/strong><a href=\"https:\/\/es.surveymonkey.com\/r\/enq_vida\">https:\/\/es.surveymonkey.com\/r\/enq_vida<\/a><\/p>\n<p><strong>Moltes gr\u00e0cies per endavant per la teva participaci\u00f3!\u00a0<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Font: ASSCAT<\/p>\n<p>[\/et_pb_text][et_pb_gallery admin_label=&#8221;Galer\u00eda de im\u00e1genes&#8221; gallery_ids=&#8221;2110,2111,2112,2113,2114,2115,3578,3573&#8243; db_images_per_row=&#8221;4&#8243; db_image_max_width_tablet=&#8221;51&#8243; db_image_max_height_tablet=&#8221;501&#8243; db_image_row_spacing_tablet=&#8221;51&#8243; db_image_center_titles=&#8221;left&#8221; db_image_object_fit=&#8221;initial&#8221; show_title_and_caption=&#8221;off&#8221; _builder_version=&#8221;3.0.106&#8243; pagination_font_size_tablet=&#8221;51&#8243; pagination_line_height_tablet=&#8221;2&#8243; background_color=&#8221;#000000&#8243; border_width_all_image=&#8221;1px&#8221; border_color_all_image=&#8221;#ffffff&#8221; custom_margin=&#8221;50px||50px|&#8221; custom_padding=&#8221;12px|12px|12px|12px&#8221; saved_tabs=&#8221;all&#8221; show_pagination=&#8221;on&#8221; fullwidth=&#8221;off&#8221; orientation=&#8221;landscape&#8221; zoom_icon_color=&#8221;#e20611&#8243; hover_overlay_color=&#8221;rgba(255,255,255,0.9)&#8221; background_layout=&#8221;light&#8221; \/][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=&#8221;Fila&#8221; custom_padding=&#8221;0px|||&#8221; _builder_version=&#8221;3.0.105&#8243; custom_margin=&#8221;|||&#8221;][et_pb_column_inner type=&#8221;4_4&#8243; saved_specialty_column_type=&#8221;2_3&#8243;][et_pb_post_title admin_label=&#8221;Metadatos &#8211; Fecha \u00daltima actualizaci\u00f3n&#8221; title=&#8221;off&#8221; author=&#8221;off&#8221; date_format=&#8221;d\/m\/Y&#8221; categories=&#8221;off&#8221; comments=&#8221;off&#8221; featured_image=&#8221;off&#8221; _builder_version=&#8221;3.0.105&#8243; title_text_align=&#8221;left&#8221; meta_font=&#8221;Open Sans||||||||&#8221; meta_text_align=&#8221;left&#8221; meta_font_size=&#8221;13px&#8221; meta_text_color=&#8221;#0082ca&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#cccccc&#8221; custom_margin=&#8221;50px|||&#8221; custom_padding=&#8221;10px|||&#8221; custom_css_before=&#8221;content:%22\u00daltima actualizaci\u00f3n:%22;&#8221; global_module=&#8221;1706&#8243; saved_tabs=&#8221;all&#8221; \/][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243;][et_pb_sidebar orientation=&#8221;right&#8221; area=&#8221;et_pb_widget_area_8&#8243; module_class=&#8221;ac-posts-sidebar&#8221; _builder_version=&#8221;3.0.106&#8243; global_module=&#8221;3198&#8243; saved_tabs=&#8221;all&#8221; \/][\/et_pb_column][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; _builder_version=&#8221;3.0.106&#8243; custom_padding=&#8221;||0px|&#8221; prev_background_color=&#8221;#000000&#8243; module_class=&#8221;ac-post-section-share-rrss&#8221;][et_pb_row custom_padding=&#8221;||0px|&#8221; custom_margin=&#8221;|||&#8221; _builder_version=&#8221;3.0.105&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_text _builder_version=&#8221;3.0.106&#8243; text_font=&#8221;Montserrat||||||||&#8221; text_text_color=&#8221;#e20611&#8243; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||0px|&#8221; custom_padding=&#8221;|||&#8221; background_layout=&#8221;light&#8221;]<\/p>\n<h5>Desde aqu\u00ed puedes compartir esta publicaci\u00f3n. \u00a1Gracias!<\/h5>\n<p>[\/et_pb_text][et_pb_divider color=&#8221;#e20611&#8243; show_divider=&#8221;on&#8221; divider_style=&#8221;ridge&#8221; _builder_version=&#8221;3.0.106&#8243; \/][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n<!-- Begin Yuzo --><div class='yuzo_related_post style-1'  data-version='5.12.77'><!-- without result --><div class='yuzo_clearfixed yuzo__title yuzo__title'><h3>Related Post<\/h3><\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/resum-del-43e-congres-de-lassociacio-espanyola-per-a-lestudi-del-fetge-aeeh\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/congreso-AEEH-150x149.jpeg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">Resum del 43\u00e8 Congr\u00e9s de l\u2019Associaci\u00f3 Espany...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/per-que-el-sistema-immunitari-de-les-dones-les-defensa-millor-de-la-covid-19\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/mujeres-covid-150x150.jpg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">Per qu\u00e8 el sistema immunitari de les dones les def...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/cronica-del-webinar-sobre-lalcohol-i-el-fetge-organitzat-per-lassociacio-americana-per-a-lestudi-del-fetge-aasld\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/01-foto-14-150x150.jpg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">Cr\u00f2nica del webinar sobre l\u2019alcohol i el fetge org...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t  <div class=\"relatedthumb \" style=\"width:125px;float:left;overflow:hidden;\">  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <a  href=\"https:\/\/asscat-hepatitis.org\/ca\/organs-vhc-positius-una-opcio-viable-per-a-pacients-de-trasplantament-no-infectats\/\"  >\n\t\t\t\t\t\t\t\t\t  <div class=\"yuzo-img-wrap \" style=\"width: 125px;height:90px;\">\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"yuzo-img\" style=\"background:url('https:\/\/asscat-hepatitis.org\/wp-content\/uploads\/trasplante-higado-150x150.jpeg') 50% 50% no-repeat;width: 125px;height:90px;margin-bottom: 5px;background-size: cover; \"><\/div>\n\t\t\t\t\t\t\t\t\t  <\/div>\n\t\t\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t\t   <span class=\"yuzo__text--title\" style=\"font-size:13px;\">\u00d2rgans VHC positius: una opci\u00f3 viable per a pacien...<\/span>\n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  \n\t\t\t\t\t\t\t  <\/a>\n\n\t\t\t\t\t\t  <\/div>\n<\/div> <style>\n\t\t\t\t\t\t\t\t.yuzo_related_post img{width:120px !important; height:110px !important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb{line-height:15px;background: !important;color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb:hover{background:#fcfcf4 !important; -webkit-transition: background 0.2s linear; -moz-transition: background 0.2s linear; -o-transition: background 0.2s linear; transition: background 0.2s linear;;color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb a{color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb a:hover{ color:}!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb:hover a{ color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .yuzo_text {color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb:hover .yuzo_text {color:!important;}\n\t\t\t\t\t\t\t\t.yuzo_related_post .relatedthumb{  margin: 0px  0px  0px  0px;   padding: 5px  5px  5px  5px;  }\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/style> <script>\n\t\t\t\t\t\t  jQuery(document).ready(function( $ ){\n\t\t\t\t\t\t\t\/\/jQuery('.yuzo_related_post').equalizer({ overflow : 'relatedthumb' });\n\t\t\t\t\t\t\tjQuery('.yuzo_related_post .yuzo_wraps').equalizer({ columns : '> div' });\n\t\t\t\t\t\t   })\n\t\t\t\t\t\t  <\/script> <!-- End Yuzo :) -->","protected":false},"excerpt":{"rendered":"<p>L&#8217;ASSCAT i gTt-VIH, en col\u00b7laboraci\u00f3 amb el CEEISCAT, posen en marxa un estudi per con\u00e8ixer quina \u00e9s la percepci\u00f3 que sobre la seva salut tenen les persones que han tingut o tenen hepatitis C.<\/p>\n","protected":false},"author":9,"featured_media":4402,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[474],"tags":[916,476,871,1181,873,498,511],"class_list":["post-5325","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-activismo-ca","tag-activisme","tag-asscat-ca","tag-ceeiscat-ca","tag-enquesta-qualitat-de-vida","tag-gtt-vih-ca","tag-hepatitis-c-ca","tag-vhc-ca"],"_links":{"self":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/posts\/5325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/comments?post=5325"}],"version-history":[{"count":0,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/posts\/5325\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/media\/4402"}],"wp:attachment":[{"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/media?parent=5325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/categories?post=5325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asscat-hepatitis.org\/ca\/wp-json\/wp\/v2\/tags?post=5325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}